Biomolex AS is a Norwegian biotech company that was established as a joint venture between The Norwegian Radium Hospital (NRH) and Ideas ASA (Ideas) in May 2001. Biomolex has developed a unique patented microarray reader – an imaging system for gene and protein analysis.
We provide tools that accelerate drug discovery, enable precision medicine and increase the quality of data in research. Our vision is to become a unique supplier of kinase arrays for diagnostics and drug development.
The Biomolex digital radiography system provides real time detection of multiple radioisotope labels. With a higher sensitivity than classical phosphorimagers, we aim to make molecular imaging more precise.